NewAmsterdam Pharma Co N.V.: insider trades · United States · SEC (Form 4) Discover the full directors' dealings record of NewAmsterdam Pharma Co N.V., a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 19 May 2025 (Levée d'options). Among the most active insiders: ForGrowth NAP B.V.. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 19 May 2025
All Executives47 Thresholds0 Prospectus0 Other0
Declarations 47 total
◇ Chief Operating Officer · Executives · 15 May 2025
100,000 shares @ US$10.00 50.2% of flow Ordinary Shares SEC:0000950170-25-074463:0
◇ Director · Executives · 1 May 2025
69 shares 0Ordinary Shares SEC:0000950170-25-062894:0
◇ Director · Executives · 14 Apr 2025
69 shares 0Ordinary Shares SEC:0000950170-25-056395:0
◇ Chief Operating Officer · Executives · 15 Apr 2025
100,000 shares @ US$10.00 49.8% of flow Ordinary Shares SEC:0000950170-25-055612:0
◆ Director · Executives · 15 Apr 2025
10,860 shares Ordinary Shares SEC:0000950170-25-055603:0
◇ Chief Operating Officer · Executives · 26 Mar 2025
16,539 shares 0Ordinary Shares SEC:0000950170-25-046943:0
◇ Director · Executives · 26 Mar 2025
3,102 shares 0Ordinary Shares SEC:0000950170-25-046958:0
▲ Director · Executives · 26 Mar 2025
1,135 shares @ US$22.4851 8.7% of flow Ordinary Shares SEC:0001415889-25-009198:0
Ideal exit: 21 Dec 2025 (T+270) ◆ Chief Executive Officer · Executives · 26 Mar 2025
30,992 shares 0Ordinary Shares SEC:0000950170-25-046934:0
◇ Chief Accounting Officer · Executives · 26 Mar 2025
8,269 shares 0Ordinary Shares SEC:0000950170-25-046962:0
◆ Chief Scientific Officer · Executives · 26 Mar 2025
19,302 shares 0Ordinary Shares SEC:0000950170-25-046947:0
◇ Chief Scientific Officer · Executives · 24 Mar 2025
150,000 shares Ordinary Shares SEC:0000950170-25-045283:0
◇ Chief Operating Officer · Executives · 17 Mar 2025
88,112 shares Ordinary Shares SEC:0000950170-25-042176:0
▲ Director · Executives · 4 Mar 2025
4,005 shares @ US$21.0245 29.6% of flow Ordinary Shares SEC:0001415889-25-007263:0
Ideal exit: 29 Nov 2025 (T+270) ◇ Chief Accounting Officer · Executives · 4 Mar 2025
150,000 shares Ordinary Shares SEC:0000950170-25-033927:0
◇ Chief Operating Officer · Executives · 18 Feb 2025
90,782 shares Ordinary Shares SEC:0000950170-25-024322:0
◇ Chief Operating Officer · Executives · 29 Jan 2025
56,863 shares Ordinary Shares SEC:0000950170-25-011854:0
◇ Chief Financial Officer · Executives · 27 Jan 2025
46,983 shares @ US$9.26 100.0% of flow Ordinary Shares SEC:0000950170-25-010594:0
◇ Chief Operating Officer · Executives · 27 Jan 2025
104,174 shares Ordinary Shares SEC:0000950170-25-010575:0
◆ Director · Executives · 7 Jan 2025
6,960 shares Ordinary Shares SEC:0000950170-25-003566:0
◆ Director · Executives · 7 Jan 2025
6,960 shares Ordinary Shares SEC:0000950170-25-003556:0
◆ Director · Executives · 7 Jan 2025
6,960 shares Ordinary Shares SEC:0000950170-25-003561:0
◆ Director · Executives · 7 Jan 2025
6,960 shares Ordinary Shares SEC:0000950170-25-003570:0
◆ Director · Executives · 7 Jan 2025
6,960 shares Ordinary Shares SEC:0000950170-25-003552:0
◆ Chief Business Officer · Executives · 7 Jan 2025
14,000 shares Ordinary Shares SEC:0000950170-25-002996:0
25 of 47 declarations
Load more (22 remaining)